Phosphorus magnetic resonance spectroscopy in schizophrenia correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 4, 1996, Pages 629-640

  Fukuzako, Hiroshi ^a   Fukuzako, Tsuyoshi ^a   Takeuchi, Kouzou ^b   Ohbo, Yoshihiko ^a   Ueyama, Kenichi ^a   Takigawa, Morikuni ^a   Fujimoto, Toshiro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b South Japan Health Science Center   (Japan)

Author keywords

Phosphorus MRS; Positive symptoms; Schizophrenia; Temporal lobe

Indexed keywords

PHOSPHORUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHOLIPID METABOLISM; SCHIZOPHRENIA; SYMPTOMATOLOGY; TEMPORAL LOBE;

EID: 0030152974     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(96)00036-X     Document Type: Article

References (36)

1. AMERICAN PSYCHIATRIC ASSOCIATION (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., Revised. American Psychiatric Press, Washington DC.
2. BUCHANAN, R.W., BREIER, A., KIRKPATRICK, B., ELKASHEF, A., MUNSON, R.C., GELLAD, F. and CARPENTER, W.T. Jr. (1993) Structural abnormalities in deficit and nondeficit schizophrenia. Am. J. Psychiatry 150: 59-65.
3. BUCHSBAUM, M.S. (1990) The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr. Bull. 16: 379-389.
4. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biol. Psychiatry 32: 26-32.
5. DEICKEN, R.F., CALABRESE, G., MERRIN, E.L., FEIN, G. and WEINER, M.W. (1995a) Basal ganglia phosphorous metabolism in chronic schizophrenia. Am. J. Psychiatry 152: 126-129.
6. DEICKEN, R.F., MERRIN, E.L., FLOYD, T.C. and WEINER, M.W. (1995b) Correlation between left frontal phospholipids and Wisconsin Card Sorting Test performance in schizophrenia. Schizophr. Res. 14: 177-181.
7. DELISI, L.E., BUCHSBAUM, M.S., HOLCOMB, H.H., LANGSTON, K.C., KING, A.C., KESSLER, R., PICKAR, D., CARPENTER, W.T. Jr., MORIHISA, J.M., MARGOLIN, R. and WEINBERGER, D.R. (1989) Increased temporal lobe glucose use in chronic schizophrenic patients. Biol. Psychiatry 25: 835-851.
8. DELISI, L.E., STRITZKE, P., RIORDAN, H., HOLAN, V., BOCCIO, A., KUSHNER, M., MCCLELLAND, J., VAN EYL, O. and ANAND, A. (1992) The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol. Psychiatry 31: 241-254.
9. DETRE, J.A., WILLIAMS, D.S. and KORETSKY, A.P. (1990) Nuclear magnetic resonance determination of flow, lactate, and phosphate metabolites during amphetamine stimulation of the rat brain. NMR Biomed. 3: 272-278.
10. 31P magnetic resonance chemical shift imaging. Acta. Psychiatr. Scand. 86: 455-462.
11. FUKUZAKO, H., FUKUZAKO, T., HASHIGUCHI, T., HOKAZONO, Y., TAKEUCHI, K., HIRAKAWA, K., UEYAMA, K., TAKIGAWA, M., KAJIYA, Y., NAKAJO, M. and FUJIMOTO, T. (1996) Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: Assessment by MRI. Biol Psychiatry (in press).
12. 31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms. Eur. Arch. Psychiatry Clin. Neurosci. 244: 236-240.
13. ITOH, H. (1985) Pharmacotherapy of schizophrenia: Its present status and controversial points. Seishin Igaku 27: 521-530 (in Japanese).
14. KESHAVAN, M.S., KAPUR, S. and PETTEGREW, J.W. (1991) Magnetic resonance spectroscopy in psychiatry. Am. J. Psychiatry 148: 976-985.
15. 31P NMR spectrum of human brain: The determination of the concentrations of phosphodiester components. FEBS Letters 272: 163-165.
16. KITAMURA, T., YUZURIHA, T., MORITA, M., ITOH, J., SUGA, R., NAKAGAWA, Y. (1990) Oxford version of the BPRS: development and validation of subscales. Psychiatr. Diag. 1: 101-107.
17. KOLAKOWSKA T (1976) Brief Psychiatric Rating Scale: Glossaries and Rating Instructions. Oxford University, Oxford.
18. LIDDLE, P.F., FRISTON, K.J., FRITH, C.D., HIRSCH, S.R., JONES, T. and FRACKOWIAK, R.S.J. (1992) Patterns of cerebral blood flow in schizophrenia. Br. J. Psychiatry 160: 179-186.
19. LOCK, T., ABOU-SALEH, M.T. and EDWARDS, R.H.T. (1990) Psychiatry and the new magnetic resonance era. Br. J. Psychiatry 157: 38-55.
20. MATHEW, R.J., WILSON, W.H., TAUT, S.R., ROBINSON, R. and PRAKASH R (1988) Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. Arch. Gen. Psychiatry 45: 542-549.
21. 31P-MRS. Jpn. J. Magn. Reson. Med. 12: 232-237 (in Japanese).
22. MURPHY, D.G.M., BOTTOMLEY, P.A., SALERNO, J.A., DECARLI, C., MENTIS, M.J., GRANDY, C.L., TEICHBERG, D., GIACOMETTI, K.R., ROSENBERG, J.M., HARDY, C.J., SCHAPIRO, M.B., RAPOPORT, S.I., ALGER, J.R. and HORWITZ, B. (1993) An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch. Gen. Psychiatry 50: 341-349.
23. 31P NMR spectrum in vivo. Magn. Reson. Med. 12: 282-289.
24. OLDFIELD, R. (1971) The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia 9: 97-113.
25. 31P NMR studies in schizophrenia. Biol. Psychiatry 25: 15A.
26. PETTEGREW, J.W., KESHAVAN, M.S., PANCHALINGAM, K., STRYCHOR, S., KAPLAN, D.B., TRETTA, M.G. and ALLEN, M. (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics: A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry 48: 563-568.
27. RUBIN, P., HEMMINGSEN, R., HOLM, S., MOLLER-MADSEN, S., HERTEL, C., POVLSEN, U.J. and KARLE, A. (1994) Relationship between brain structure and function in disorders of the schizophrenic spectrum: single positron emission computerized tomography and psychopathology of first episodes. Acta. Psychiatr. Scand. 90: 281-289.
28. SCHACHTER, S.C., RANSIL, B.J. and GESCHWIND (1987) Associations of handedness with hair color and learning disabilities. Neuropsychologia 25: 269-276.
29. SHIOIRI, T., KATO, T., INUBUSHI, T., MURASHITA, J. and TAKAHASHI, S. (1994) Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Res.: Neuroimag. 55: 223-235.
30. 31P MRS study of clozapine vs haloperidol effects on brain metabolism. Biol. Psychiatry 37: 648.
31. STANLEY, J.A., WILLIAMSON, P.C., DROST, D.J., CARR, T.J., RYLETT, R.J., MALLA, A. and THOMPSON RT (1995) An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry 52: 399-406.
32. SUDDATH, R.L., CASANOVA, M.F., GOLDBERG, T.E., DANIEL, D.G., KELSOE, J.R. Jr. and WEINBERGER, D.R. (1989) Temporal lobe pathology in schizophrenia: A quantitative magnetic resonance imaging study. Am. J. Psychiatry 146: 464-472.
33. 123I-IMP SPECT. Eur. Arch. Psychiatry Clin. Neurosci. 242: 257-261.
34. WIESEL, F.A., WIK, G., SJöREN, I., BLOMQVIST, G., GREITZ, T. and STONE-ELANDER, S. (1987) Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta. Psychiatr. Scand. 76: 628-641.
35. WOLF, S.S., HYDE, T.M. and WEINBERGER, D.R. (1993) Neurobiology of schizophrenia. Curr. Opin. Neurol. Neurosurg. 6: 86-92.
36. WOLKIN, A., JAEGER, J., BRODIE, J.D., WOLF, A.P., FOWLER, J., ROTROSEN, J., GOMEZ-MONT, F. and CANCRO, R. (1985) Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am. J. Psychiatry 142: 564-571.